Molecular profiling of clinical tissue specimens: Feasibility and applications

American Journal of Pathology

Volumn 156, Issue 4, 2000, Pages 1109-1115

  Emmert Buck, Michael R ^a   Strausberg, Robert L ^a   Krizman, David B ^a   Bonaldo, M Fatima ^b   Bonner, Robert F ^c   Bostwick, David G ^d   Brown, Monica R ^a,d   Buetow, Kenneth H ^a   Chuaqui, Rodrigo F ^a   Cole, Kristina A ^a   Duray, Paul H ^a   Englert, Chad R ^a   Gillespie, John W ^a   Greenhut, Susan ^a   Grouse, Lynette ^a   Hillier, LaDeana W ^e   Katz, Kenneth S ^a   Klausner, Richard D ^a   Kuznetzov, Vladimir ^c   Lash, Alex E ^f   Lennon, Greg ^g   Linehan, W Marston ^a   Liotta, Lance A ^a   Marra, Marco A ^h   Munson, Peter J ⁱ   Ornstein, David K ^a   Prabhu, Vinay V ⁱ   Prange, Christa ^g   Schuler, Gregory D ^f   Soares, Marcelo Bento ^b   Tolstoshev, Carolyn M ^f   Vocke, Cathy D ^a   Waterston, Robert H ^e   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d BOSTWICK LABORATORIES   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^h BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

ⁱ NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA;

CANCER GENETICS; CLINICAL ARTICLE; GENE EXPRESSION; GENETIC VARIABILITY; GENOME; HUMAN; HUMAN TISSUE; MALE; MOLECULAR BIOLOGY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

EID: 0033843502     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64979-6     Document Type: Article

References (52)

1. New goals for the U.S. human genome project, 1998-2003
2. Shotgun sequencing of the human genome
3. 3, 400 new expressed sequence tags identify diversity of transcripts in human brain
4. Generation and analysis of 280 000 human expressed sequence tags
5. The I.M.A.G.E. Consortium: An integrated molecular analysis of genomes and their expression
6. A physical map of 30, 000 human genes
7. The mammalian gene collection
8. Quantitative monitoring of gene expression patterns with a complementary DNA microarray
9. Use of a cDNA microarray to analyse gene expression patterns in human cancer
10. Entering the postgenome era
11. Serial analysis of gene expression
12. Gene expression profiles in normal and cancer cells
13. Multiplexed biochemical assays with biological chips
14. High density synthetic oligonucleotide arrays
15. Gene expression profiles of laser-captured adjacent neuronal subtypes
16. Drug target validation and identification of secondary drug target effects using DNA microarrays
17. Exploring the new world of the genome with DNA microarrays
18. Microarrays and macroconsequences
19. Going global
20. Array of hope
21. Pattern recognition and arrays: The times are a-changing
22. The genetics of cancer: A 3D model
23. New opportunities for uncovering the molecular basis of cancer
24. A catalog of cancer genes at the click of a mouse
25. The Cancer Genome Anatomy Project: Building an annotated gene index
26. Immunotoxins that target an oncogenic mutant epidermal growth factor receptor expressed in human tumors
27. Review of allelic loss and gain in prostate cancer
28. Molecular advances in prostate cancer
29. Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia (PIN)
30. Loss of chromosome arm 8p loci in prostate cancer: Mapping by quantitative allelic imbalance
31. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search
32. Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer
33. Evidence for a prostate cancer susceptibility locus on the X chromosome
34. Localization of the multiple endocrine neoplasia type I (MEN1) gene based on tumor deletion mapping
35. 11q13 Allelotype analysis in 27 northern american MEN1 kindreds identifies two distinct founder chromosomes
36. Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene
37. Positional cloning of the gene for multiple endocrine neoplasia type 1
38. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
39. Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung
40. Development of a prostate cDNA microarray and statistical gene expression analysis package
41. Reliable identification of large numbers of candidate SNPs from public EST data
42. PB39: Identification of a novel gene up-regulated in clinically aggressive human prostate cancer
43. cDNA sequencing and analysis of PB39: A novel gene up-regulated in prostate cancer
44. Increased gelatinase A and cathepsin B activity in invasive tumor regions of human colon cancer samples
45. Laser capture microdissection
46. Laser capture microdissection: Molecular analysis of tissue
47. Immuno-LCM: Laser capture microdissection of immunostained frozen sections for mRNA analysis
48. Identification of expressed genes by laser-mediated manipulation of single cells
49. Construction of a representative cDNA library from prostatic intraepithelial neoptasia (PIN)
50. An improved method for construction of directionally cloned cDNA libraries from microdissected cells
51. Discovery of three genes specifically expressed in human prostate by expressed sequence tag database analysis
52. High expression of a specific T-cell receptor gamma transcript n epithelial cells of the prostate